Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.30

Mkt cap

1.6B

Volume

197K

High

2.30

P/E Ratio

-7.03

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

2.07

The U.S. House Committee on Agriculture approved an amendment to the new Farm Bill that would eliminate most hemp-derived products, including those with any level of THC. This amendment aims to close a loophole from the 2018 Farm Bill that allowed intoxicating hemp products like Delta-8 THC to be sold. The amendment has sparked a divide between the cannabis and hemp industries, with significant opposition from hemp advocates and some cannabis companies supporting stricter regulations.

Portfolio Pulse from Nina Zdinjak

May 24, 2024 | 12:59 pm

Jushi Holdings Inc. (OTC:JUSHF) is poised for substantial growth with potential adult-use cannabis legalization in Ohio and Pennsylvania, and continuous expansion in Virginia’s medical market. Rescheduling of cannabis could provide $514 million in tax breaks, nearly quadrupling the company's market cap. Despite a slight decline in Q1 2024 sales, the company shows positive cash flow and improved margins.

Portfolio Pulse from Nicolás Jose Rodriguez

May 22, 2024 | 7:27 pm

The article discusses the impact of trading volume on cannabis stocks, highlighting both high-liquidity and low-liquidity stocks. High-liquidity stocks like SNDL, Tilray Brands, Cronos Group, and Aurora Cannabis offer reduced transaction costs and flexibility but can be volatile. Low-liquidity stocks like Medical Marijuana, Trees, Curaleaf Holdings, and Green Thumb Industries may offer high returns but come with higher transaction costs and potential price impacts.

Portfolio Pulse from Nicolás Jose Rodriguez

May 20, 2024 | 10:54 pm

Four small-cap cannabis stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms International—showed positive performance despite the broader sector's downtrend. These stocks present potential investment opportunities due to their operational efficiencies and financial metrics. In contrast, larger cannabis companies like Curaleaf Holdings, AdvisorShares Pure US Cannabis ETF, Canopy Growth, Trulieve Cannabis, and Green Thumb Industries experienced declines, with only Aurora Cannabis showing a slight increase.

Portfolio Pulse from Nicolás Jose Rodriguez

May 20, 2024 | 8:44 pm

Marijuana stocks experienced a bearish Monday with several companies seeing significant losses. Notable gainers included Heritage Cannabis Holding, 1933 Industries, and Target Group. Major losers included Flower One Holdings, Elixinol Wellness, and Pharmadrug.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 8:30 pm

The Biden administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act, which could revolutionize the cannabis industry. This change will allow marijuana businesses to deduct operational expenses, potentially increasing cash flow by up to 500% for major players. Key stocks to watch include Johnson & Johnson, MindMed, Cybin Inc., Pfizer, Amgen, Teva Pharmaceutical Industries, AbbVie, and Jazz Pharmaceuticals.

Portfolio Pulse from Nicolás Jose Rodriguez

May 18, 2024 | 2:19 pm

President Joe Biden announced a significant move to reschedule marijuana from a Schedule I to a Schedule III drug under federal law. This decision is expected to have a positive impact on cannabis-related stocks, as evidenced by the immediate rise in their prices following the announcement.

Portfolio Pulse from Maureen Meehan

May 16, 2024 | 6:02 pm

The Benzinga Cannabis Capital Conference, in partnership with Curaleaf's corporate philanthropy arm, Rooted In Good, has launched the 2024 Canna Founders Pitch Competition. The event, set for June 17, 2024, in New Brunswick, New Jersey, aims to support diverse and minority-owned cannabis businesses by offering substantial prizes and exposure opportunities.

Portfolio Pulse from Javier Hasse

May 16, 2024 | 2:52 pm

Wedbush Securities upgraded Curaleaf Holdings, Inc. (OTC:CURLF) to Outperform, raising its 12-month price target to $7.00. Curaleaf, the largest U.S. cannabis company by market cap, reported Q1 2024 revenue of $338.9 million and projects $1.5 billion in revenue for 2025. The company is expanding domestically and internationally, with new product lines expected to contribute to long-term growth. Updated guidance anticipates consistent quarterly revenue growth, with a 2025 EBITDA forecast of $404 million.

Portfolio Pulse from Nicolás Jose Rodriguez

May 14, 2024 | 9:32 pm

Smart and Safe Florida has launched a campaign with four ads advocating for the legalization of recreational marijuana in Florida, known as Amendment 3, set for a vote in November 2024. The campaign, supported by major cannabis companies including Trulieve, Verano Holdings, Curaleaf Holdings, AYR Wellness, Cresco Labs, Green Thumb Industries, and INSA, has spent over $5 million on ads. Trulieve alone has contributed over $40 million towards the initiative. The ads emphasize the benefits of a regulated market, including safety, revenue for schools, and freedom from outdated laws.

Portfolio Pulse from Maureen Meehan

May 14, 2024 | 9:21 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.